AFT Annual Meeting Results 2018

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland, 0622, New Zealand
Incorporated in New Zealand ARBN: 609 017 969





Market Release

3 August 2018


2018 Annual Meeting Results

At AFT Pharmaceuticals Limited’s (NZX:AFT/ASX:AFP) Annual Meeting in Auckland today
shareholders were asked to vote on three resolutions, all of which were supported by the
Board. All resolutions were decided by poll and passed by shareholders.

The ordinary resolutions passed by shareholders today were:

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor
for the 2019 financial year.
2. That Mr David Flacks be re-elected as a director of AFT.
3. That Dr James (Jim) Burns be re-elected as a director of AFT.

Details of the total number of votes cast in person or by a proxy holder on a poll are:


Resolution

For Against Abstain
Fix auditor’s
remuneration

89,400,430
100.00%
-
-

1,141
-

Re-elect Mr Flacks 89,390,185
99.99%
10,245
0.01%

1,141
-

Re-elect Dr Burns 89,400,430
100.00%

-
-

1,141
-


ENDS

For investor relations queries please contact:
Malcolm Tubby
Chief Financial Officer
AFT Pharmaceuticals Ltd
Phone: +64 9 488 0232 (x703)
Mobile: +64 21 36 88 69
Email: investor.relations@aftpharm.com